Industry | 2023.03.01
ProPharma Announces the Appointment of Karl Deonanan as Chief Financial Officer to Support Next Phase of Growth
ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and quality services for the life sciences industry and a portfolio company of Odyssey Investment Partners, announces the appointment of Karl Deonanan to the Executive Leadership Team as the Chief Financial Officer (CFO).
(PRWeb March 01, 2023)
Read the full story at https://www.prweb.com/releases/propharma_announces_the_appointment_of_karl_deonanan_as_chief_financial_officer_to_support_next_phase_of_growth/prweb19195188.htm
For more information, please visit
https://www.prweb.com/releases/propharma[...]se_of_growth/prweb19195188.htm
